Bausch & Lomb Corp Business Finance Contracts & Agreements
9 Contracts & Agreements
- Assignment Agreements (4 contracts)
- Loan Agreements (1)
- Registration Rights Agreements (1)
- Share Agreements (1)
- Stock Agreements (1)
- Underwriting Agreements (1)
- Stock and Asset Purchase Agreement by and among Buyer, Novartis and, for the limited purposes set forth therein, the Company, dated as of June 30, 2023 (Filed With SEC on July 7, 2023)
- Assignment, Assumption and Amendment Agreement between Bausch Health Companies Inc., Bausch + Lomb Corporation and Joseph F. Gordon dated as of January 3, 2022 (Filed With SEC on March 31, 2022)
- Assignment, Assumption and Amendment Agreement between Bausch Health Companies Inc., Bausch + Lomb Corporation and Christina M. Ackermann dated as of January 3, 2022 (Filed With SEC on March 31, 2022)
- Assignment, Assumption and Amendment Agreement between Bausch Health Companies Inc., Bausch + Lomb Corporation and Sam A. Eldessouky dated as of January 3, 2022 (Filed With SEC on March 31, 2022)
- Assignment, Assumption and Amendment Agreement between Bausch Health Companies Inc., Bausch + Lomb Corporation and Joseph Papa dated as of January 3, 2022 (Filed With SEC on March 31, 2022)
- Loan Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of January 1, 2022 (Filed With SEC on March 31, 2022)
- Registration Rights Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of March 30, 2022 (Filed With SEC on March 31, 2022)
- Form of Common Share Certificate (Filed With SEC on March 31, 2022)
- Form of Underwriting Agreement (Filed With SEC on January 13, 2022)
